New EU Task Force Finalizes First Document
Executive Summary
As news emerges that the Transitional Measures Task Force has issued a Q&A paper, the first document to be issued by this group charged with facilitating the EU regulatory overhaul, Medtech Insight explains the different roles of the TMTF and some other key organizations involved in MDR/IVDR implementation.
You may also be interested in...
EU Regulatory Reads, January 2018: Brexit And New Reg-Deadline Minefields
2018 has had a bumpy start in the realm of EU regulations. The tangled Brexit issue has some in industry playing Russian roulette, while other deadlines are causing concerns. These issues and more were covered in the most popular Medtech Insight EU regulation stories from January.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.